β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2145-2151

  Ge, Wen Song ^a   Wang, Yao Jun ^b   Wu, Jian Xin ^a   Fan, Jian Gao ^a   Chen, Ying Wei ^a   Zhu, Liang ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Hepatic stellate cells; RNA interference; catenin

Indexed keywords

BETA CATENIN; SMALL INTERFERING RNA; WNT PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROGENESIS; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; RAT; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; BETA CATENIN; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; COLLAGEN TYPE III; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; WNT SIGNALING PATHWAY;

EID: 84899700554     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2099     Document Type: Article

References (36)

1. Moreira RK: Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 131: 1728-1734, 2007.
2. Gäbele E, Brenner DA and Rippe RA: Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 8: d69-d77, 2003. (Pubitemid 39069964)
3. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250, 2000.
4. Morrisey EE: Wnt signaling and pulmonary fibrosis. Am J Pathol 162: 1393-1397, 2003.
5. Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004. (Pubitemid 39150127)
6. Jiang F, Parsons CJ and Stefanovic B: Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol 45: 401-409, 2006. (Pubitemid 44142112)
7. Jiao J, Friedman SL and Aloman C: Hepatic fibrosis. Curr Opin Gastroenterol 25: 223-229, 2009.
8. Nejak-Bowen K and Monga SP: Wnt/beta-catenin signaling in hepatic organogenesis. Organogenesis 4: 92-99, 2008.
9. Chen SW, Chen YX, Zhang XR, et al: Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther 15: 1424-1435, 2008.
10. Scheuer PJ: The nomenclature of chronic hepatitis: time for a change. J Hepatol 22: 112-114, 1995.
11. Scheuer PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372-374, 1991.
12. Vogel S, Piantedosi R, Frank J, et al: An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41: 882-893, 2000. (Pubitemid 30434319)
13. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002. (Pubitemid 34969582)
14. Friedman SL: Hepatic fibrosis - overview. Toxicology 254: 120-129, 2008.
15. Connolly MK, Bedrosian AS, Mallen-St Clair J, et al: In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 119: 3213-3225, 2009.
16. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669, 2008.
17. MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26, 2009.
18. Habas R and Dawid IB: Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol 4: 2, 2005.
19. Gordon MD and Nusse R: Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281: 22429-22433, 2006.
20. He X, Semenov M, Tamai K and Zeng X: LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131: 1663-1677, 2004. (Pubitemid 38559836)
21. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
22. Young CS, Kitamura M, Hardy S and Kitajewski J: Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol 18: 2474-2485, 1998. (Pubitemid 28183417)
23. Schmidt-Ott KM and Barasch J: WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 74: 1004-1008, 2008.
24. Surendran K, McCaul SP and Simon TC: A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol 282: F431-F441, 2002. (Pubitemid 34654531)
25. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD and McCaughan GW: Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49: 565-576, 2001. (Pubitemid 32896989)
26. Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES and Buendia MA: Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 155: 703-710, 1999. (Pubitemid 29426815)
27. Monga SP, Pediaditakis P, Mule K, Stolz DB and Michalopoulos GK: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33: 1098-1109, 2001. (Pubitemid 32378208)
28. Sodhi D, Micsenyi A, Bowen WC, et al: Morpholino oligonucleotide- triggered beta-catenin knockdown compromises normal liver regeneration. J Hepatol 43: 132-141, 2005. (Pubitemid 40805284)
29. Cadoret A, Ovejero C, Terris B, et al: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21: 8293-8301, 2002. (Pubitemid 35477869)
30. Si-Tayeb K, Lemaigre FP and Duncan SA: Organogenesis and development of the liver. Dev Cell 18: 175-189, 2010.
31. Nejak-Bowen KN, Thompson MD, Singh S, et al: Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology 51: 1603-1613, 2010.
32. Audard V, Grimber G, Elie C, et al: Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol 212: 345-352, 2007. (Pubitemid 47017988)
33. Kim M, Lee HC, Tsedensodnom O, et al: Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 48: 780-791, 2008.
34. Cheng JH, She H, Han YP, et al: Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 294: G39-G49, 2008.
35. He W, Dai C, Li Y, et al: Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776, 2009.
36. Kim TH, Kim SH, Seo JY, et al: Blockade of Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med 223: 45-54, 2011.